In the letter, Astellas said its reasoning was to “uphold the integrity of the 340B program and address the risk of duplicate discounts and diversion.” Safety-net hospitals without an in-house pharmacy will be allowed to order Xtandi at the discounted price through one contract pharmacy.
The drugmaker will be the 24th pharmaceutical company to curb products discounted through the federal 340B program, nonprofit organization 340B Health said July 3.
The nonprofit said the decision is “depriving hospitals of crucial resources,” and it is watching two federal appeals court cases on the matter of contract pharmacies in the 340B program.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
